Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

Ascend Vitality review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

Semaglutide: $199/mo monthly; $297 first 3 months; tirzepatide: $249/mo monthly; $447 first 3 months. First three-month offers are $297 and $447; later quarterly renewal amounts are not stated.

$199/mo
See plans at Ascend Vitality
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

Ascend Vitality at a glance

Semaglutide
$199/mo monthly; $297 first 3 months
Tirzepatide
$249/mo monthly; $447 first 3 months
Coverage
Ascend Vitality's own site contradicts itself
Brand-name
Compounded only

How we scored Ascend Vitality

Every factor comes from Ascend Vitality's own published pricing, disclosures and oversight, and the six combine into the 40/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance20/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit25/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs55/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost50/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support45/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness55/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

Semaglutide: $199/mo monthly; $297 first 3 months; tirzepatide: $249/mo monthly; $447 first 3 months. First three-month offers are $297 and $447; later quarterly renewal amounts are not stated.

Pricing

MedicationPricePlan
Compounded semaglutide$199Injectable$199/mo monthly; $297 first 3 months. First three-month offers are $297 and $447; later quarterly renewal amounts are not stated.
Compounded tirzepatide$249Injectable$249/mo monthly; $447 first 3 months. First three-month offers are $297 and $447; later quarterly renewal amounts are not stated.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Ascend Vitality's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Semaglutide: $199/mo monthly; $297 first 3 months; tirzepatide: $249/mo monthly; $447 first 3 months.
  • LegitScript certified with FDA-registered-facility and 503A-pharmacy badges displayed
  • Both semaglutide and tirzepatide available as injectables

The caveats

  • First three-month offers are $297 and $447; later quarterly renewal amounts are not stated.
  • Its own site gives two contradictory answers on state coverage — confirm your state directly before paying
  • No postpartum, breastfeeding or PCOS-specific guidance found

The ordinary monthly offer and the first-quarter promotion differ

Ascend Vitality lists compounded injectable semaglutide at $199 a month and tirzepatide at $249 on its monthly offers. It also advertises first-three-month packages of $297 for semaglutide and $447 for tirzepatide. Those promotional totals should not be presented as the ongoing charge after every three-month period.

The later quarterly renewal amounts are not stated in the public-price information. A buyer considering the introductory package should therefore ask what payment follows it, whether the program renews automatically and how the selected supply is delivered. The first-quarter average can be attractive without establishing the maintenance budget. Compare ordinary monthly plans with ordinary monthly plans, and treat the introductory package as a separate commitment with its own conditions.

Coverage is described two different ways

Ascend’s site states availability across all fifty states and Washington, D.C., but another statement excludes Louisiana, Mississippi, Kansas, New Mexico and West Virginia. The public material does not resolve that difference. A reader should not simply choose the broader answer because it makes the offer look more accessible.

Confirm the actual medication and address before authorizing payment, including whether the prescribing practice and dispensing pharmacy can both serve the location. If the clinician recommends changing form or molecule, ask whether the same availability applies. A general national-coverage claim is not confirmation that every treatment is offered everywhere or that an individual patient will qualify.

Badges do not change the compounded product’s status

The site displays LegitScript certification and references FDA-registered facilities and 503A pharmacies. Those descriptions concern different aspects of the service and supply chain. They should not be combined into a claim that the compounded semaglutide or tirzepatide itself is FDA-approved. Ascend also publishes the disclosure that FDA does not review or approve compounded medications for safety or effectiveness.

Ask which pharmacy will dispense the actual prescription and what formulation and instructions apply. A provider’s badge collection does not identify every order’s dispenser or guarantee a particular result. The useful comparison is between the concrete clinical and pharmacy arrangements, with the product’s regulatory status stated accurately.

Injectable and tablet routes need separate prices

Both molecules appear as injectable products with published amounts. Oral or tablet forms also appear in the navigation, but no separate complete tablet price was established in the public treatment information. An injectable charge should not be copied to an oral product merely because both are listed under the same medication name.

If avoiding injections is central to the decision, ask the prescriber about the exact oral formulation and request its own quote. A compounded oral preparation is not automatically equivalent to an FDA-approved oral medicine or to the injection’s evidence and instructions. The formulation choice should be made with the treating clinician rather than by selecting whichever item appears easiest to buy.

Establish the exit terms before the promotion ends

Ascend uses cancel-anytime language, but that does not itself establish a right to recover money for an already-processed prescription or unused part of a prepaid introductory package. Obtain the applicable cancellation deadline, refund conditions and renewal amount before the first payment. A dated storewide promotion should not be relied on as a permanent reduction in the ordinary treatment charge.

The public service information does not set out a dedicated postpartum, breastfeeding or PCOS pathway. Someone choosing care around one of those concerns should ask how the prescriber will address it rather than inferring specialist expertise from broad wellness positioning. Ascend is most assessable when its monthly price fits the budget and the actual state and pharmacy arrangements are confirmed. The three-month offer may lower the initial expenditure, but it should remain a clearly labeled promotion rather than the answer to the entire ongoing treatment decision.

The bottom line for mothers

Best for: Readers who can compare the full payment commitment and confirm the renewal amount before choosing a plan.

Alternatives to Ascend Vitality

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Bodybuilding Health+ does the disclosure part better than most of this market and the branding part more loosely. It names four compounding pharmacies outright with phone numbers, and it names two lead physicians with their NPI numbers — both of whom check out as active MDs in the federal registry. Pricing is flat at every dose and public before any intake: $179 a month for compounded semaglutide and $209 for tirzepatide, dropping to about $142 and $175 only if you buy a bundle up front. The looser part is the name. The operator is Dynamo Group LLC of Boca Raton, not Bodybuilding.com, and the 'trusted by millions since 1999' line on the page is the licensor's heritage rather than the clinic's. It's compounded-only, so there's no FDA-approved Wegovy or Zepbound route, the bundle discounts come with no published refund terms, and a prominent '4.8 (200+ reviews)' badge sits above a Trustpilot widget whose rating we could not confirm.

    Visit Bodybuilding Health+
  • $197/mo semaglutide and $297/mo tirzepatide, everything included — medication, physician consult, supplies and shipping — compounded in the USA with no hidden fees. No state list is published anywhere we could find.

    Visit RNK Health

Providers like Ascend Vitality

Keep comparing Ascend Vitality

Ascend Vitality, answered

How much does Ascend Vitality cost?
Semaglutide: $199/mo monthly; $297 first 3 months; tirzepatide: $249/mo monthly; $447 first 3 months. First three-month offers are $297 and $447; later quarterly renewal amounts are not stated.
Which states does Ascend Vitality serve?
Its own site gives two different answers — one page claims all 50 states plus D.C., another excludes five (Louisiana, Mississippi, Kansas, New Mexico, West Virginia). Confirm your own state directly with Ascend Vitality before paying; don't assume either claim.
Is there an oral (tablet) option?
Tablet forms for both semaglutide and tirzepatide appear in Ascend Vitality's site navigation, but no separate published price was found for either — ask directly rather than assuming price parity with the injectable.

Pricing, states and verification reflect Ascend Vitality's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers